Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.40 (0.48%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £87.21m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Re ProReveal

24 Jul 2013 07:01

RNS Number : 9861J
Scientific Digital Imaging Plc
24 July 2013
 

Scientific Digital Imaging Plc

 

Scientific Digital Imaging's ProReveal to be used to train professionals

at Eastwood Park

 

Cambridge, UK 24 July 2013: Scientific Digital Imaging (AIM: SDI, "SDI" or the "Company"), the AIM quoted group focused on the application of digital imaging technology to the needs of the scientific community, is pleased to announce that the major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to supplement the training of validation professionals on how to assess the efficacy of the decontamination processes.

 

The highly sensitive ProReveal, developed by SDI's Synoptics Health Division, is an in-situ fluorescence test which can detect nanogram levels of protein. It will be used on decontamination courses (compliant with EU and UK guidelines), to train senior personnel from UK and international decontamination validation and sterile services departments (SSDs).

 

Bruce Garbutt, Training Consultant at Eastwood Park said: "Protein decontamination is the ultimate in cleaning efficacy. If your process has removed protein you know your surgical instruments can be made safe to re-use. It is possible to infect patients with prion diseases like vCJD if the cleaning processes are not optimal and we have begun to realise how swab tests to detect prion levels can be flawed, hence the imperative for an 'in situ' test such as ProReveal."

 

Paul Ellwood, SDI Synoptics Health's CEO concluded: "Eastwood Park is a very progressive training centre and their adoption of the ProReveal test shows that they are preparing decontamination professionals to comply with the new quality standards. Their commitment to improving their decontamination processes will ensure professionals will be able to quickly and easily implement the ProReveal technology in their own facilities, to easily meet the upcoming minimum safe residual protein contamination guideline level being set by the Department of Health."

 

-Ends-

For Further Information Contact:

 

Scientific Digital Imaging:

 

Mike Creedon, Chief Executive of SDI - 01223 727144

Paul Ellwood, Chief Executive of Synoptics Health - 01223 727129

 

JW Communications

Julia Wilson, Investor & Public Relations - 0781 8430877

 

finnCap - 020 7220 0500

 

Ed Frisby/Rose Herbert -Corporate Finance

Simon Starr -Corporate Broking

 

 

 

Note to Editors

 

Scientific Digital Imaging Plc

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. Within Synoptics, the recently formed Synoptics Health division has launched the Synoptics Health ProReveal system. This patented system offers a highly sensitive fluorescence-based test to detect dirty surgical instruments in hospitals and aims to reduce incidences of cross contamination of patients. In addition, under the Atik brand, SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications. www.scientificdigitalimaging.com

 

 

Eastwood Park

 

Eastwood Park in Gloucestershire, UK is widely acknowledged as a leading training centre, with an international reputation. It delivers specialist medical equipment, engineering, decontamination, facilities management and estates training, primarily to the healthcare and commercial facilities management sectors.

 

Most of the training offered is unique and is accredited by internationally recognised Awarding Bodies. Courses are regularly updated and new courses developed responding to new technologies, the latest official guidelines and individual sector developments.

 

Established 40 years, Eastwood Park maintains its commitment to delivering quality training as much today as the day it started in this vital sector.

www.eastwoodparktraining.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUORNROUABUAR
Date   Source Headline
10th Jun 20267:00 amRNSDirectorate change
21st May 20267:00 amRNSTrading Update
11th May 20261:00 pmRNSDirectorate change
10th Apr 20264:40 pmRNSHolding(s) in Company
9th Apr 20265:05 pmRNSHolding(s) in Company
20th Mar 202610:45 amRNSHolding(s) in Company
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
13th Mar 20261:41 pmRNSHolding(s) in Company
2nd Mar 20266:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20263:45 pmRNSHolding(s) in Company
13th Feb 20267:00 amRNSAcquisition of PRP Optoelectronics
3rd Dec 20257:00 amRNSInterim Results
17th Nov 20257:00 amRNSNotice of Results and Investor Presentation
7th Oct 20254:49 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
25th Sep 20257:00 amRNSGrant of Share Option Awards
24th Sep 20252:30 pmRNSResult of AGM
24th Sep 20257:00 amRNSAGM Trading Update
19th Sep 20253:31 pmRNSHolding(s) in Company
21st Aug 20257:00 amRNSPosting of Annual Report and Notice of AGM
30th Jul 20257:00 amRNSFinal Results
21st Jul 20257:00 amRNSNotice of Results and Investor Presentation
26th Jun 20252:14 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Jun 20257:00 amRNSAcquisition of Severn Thermal Solutions
19th May 20257:00 amRNSTrading Update
6th May 20257:00 amRNS-RInspecVision awarded King's Award for Enterprise
11th Apr 20253:00 pmRNSHolding(s) in Company
4th Apr 20251:55 pmRNSDirector / PDMR Shareholding
4th Apr 20257:00 amRNSAcquisition of Collins Walker
20th Mar 20257:00 amRNS-RNews from Portfolio Companies
14th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSNotice of Results and Investor Presentation
30th Oct 20247:00 amRNSAcquisition of InspecVision
14th Oct 202410:00 amRNSHoldings in Company
7th Oct 20245:00 pmRNSHolding(s) in Company
27th Sep 20247:00 amRNSShare Option Awards
26th Sep 20243:00 pmRNSDirector/PDMR Shareholding
26th Sep 20241:05 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Trading Update
28th Aug 20247:00 amRNSPosting of Annual Report & Accounts & AGM Notice
30th Jul 20247:00 amRNSFinal Results
23rd Jul 20241:00 pmRNSNotice of Results and Investor Presentation
4th Jul 202411:45 amRNSHolding(s) in Company
3rd Jul 20244:25 pmRNSHolding(s) in Company
23rd May 202411:30 amRNSHolding(s) in Company
20th May 20247:00 amRNSTrading Update
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.